Clinical trials
Endometrial clinical trials
Below are recruiting endometrial clinical trials, each written for real people, not researchers. We’re tracking 364 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06751589RecruitingEarly Phase 1
Weight loss drug study for people with endometrial cancer
This study tests if adding a weight loss medication (tirzepatide or semaglutide) during chemotherapy helps people with early-stage endometrial cancer who are overweight or have diabetes. It aims to see if weight loss can improve treatment outcomes.
Basking Ridge, New JerseyAges 18 years+ - NCT06846775Recruiting
DNA test in urine and vaginal samples for endometrial cancer
This study tests if a DNA test in urine and vaginal samples you collect at home can help find endometrial cancer. It compares results from people with the cancer to healthy volunteers.
Aarhus NAges 60 years+ - NCT06855706Recruiting
Personalized physical activity program for ovarian and endometrial cancers
This study tests whether a personalized, automated physical activity program (using a Fitbit and continuous glucose monitor) can improve immune function and health outcomes in people with advanced ovarian, primary peritoneal, fallopian tube, or newly diagnosed endometrial cancer. You'll wear an activity tracker, answer questionnaires, and provide blood and stool samples at Roswell Park.
Buffalo, New YorkAges 18 years+ - NCT06864494Recruiting
Testing a protein marker for adenomyosis diagnosis
This study measures a protein called L-PGDS (lipocalin-type prostaglandin D synthase) in blood, urine, and tissue samples to see if it can help diagnose adenomyosis (a condition that causes heavy periods and pelvic pain). Researchers are comparing levels in women with and without adenomyosis who are having a hysterectomy, as well as in women without symptoms.
NîmesAges 18–57 - NCT06870903Recruiting
Comparing two lymph node removal methods in vaginal surgery for early endometrial cancer
This trial compares two ways of removing lymph nodes during a vaginal minimally invasive surgery for early-stage endometrial cancer. It aims to find which method is safer and more effective.
Diyarbakır, BaglarAges 18–85 - NCT06890273Recruiting
Study of durvalumab and olaparib for endometrial cancer
This study looks at how well two drugs, durvalumab and olaparib, work together after initial chemotherapy for advanced or recurrent endometrial cancer. It may help patients who have not had many treatment options before.
AmbergAges 18–130 - NCT06893861Recruiting
Testing a new blood test for endometrial cancer screening
This study is testing whether a blood test that looks at small molecules (metabolites) can help find endometrial cancer early in post-menopausal women. If you are between 50 and 80 years old and have not had a hysterectomy or certain hormone treatments, you may be able to join.
NaplesAges 50–80 - NCT06896747RecruitingPhase 1/Phase 2
Stem cell therapy for thin uterine lining
This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.
Xi'an, ShaanxiAges 20–40 - NCT06925724RecruitingPhase 2
Ivonescimab for endometrial and cervical cancer
This trial tests a new drug called ivonescimab for people with advanced endometrial or cervical cancer that has spread or come back after platinum-based chemotherapy. The goal is to see if the drug can help shrink or slow the cancer.
Basking Ridge, New JerseyAges 18 years+ - NCT06935305Recruiting
Testing a faster method to find cancer in sentinel lymph nodes
This trial compares a fast lab test (OSNA) with standard microscope checks to see which better finds cancer in the first lymph node (sentinel node) during surgery for early-stage endometrial cancer. It aims to improve accuracy and speed while avoiding unnecessary lymph node removal.
Rome, ItalyAges Any age - NCT06995833Recruiting
Durvalumab with or without Olaparib for endometrial cancer
This trial collects safety information on the standard use of Durvalumab (with or without Olaparib) in people with endometrial cancer in Korea. It helps doctors confirm the real-world effects of these approved treatments.
SeoulAges Any age - NCT07025213Recruiting
Exercise and diet study for endometrial cancer before surgery
This study tests whether combining exercise with a special diet can improve how your body processes energy (metabolism) before you have surgery to remove the cancer. It is for people with early-stage endometrial cancer who haven't yet started treatment.
México, TlalpanAges 18–65 - NCT07027046Recruiting
A new robotic tool for endometrial cancer surgery
This trial is testing a newer, single-port robotic system (da Vinci SP) for staging surgery in endometrial cancer. It aims to see if this system is safe and effective for removing the uterus, ovaries, and possibly lymph nodes, with less scarring.
Naples, NapoliAges 18 years+ - NCT07054567RecruitingPhase 2
Study of BL-B01D1 plus Keytruda for advanced cervical or endometrial cancer
This trial tests a new drug combination for people with cervical or endometrial cancer that has come back or spread. The study aims to see if adding BL-B01D1 to Keytruda (with or without Avastin) can help shrink tumors or slow the cancer's growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07065552RecruitingEarly Phase 1
Tirzepatide for weight-linked endometrial cancer
This trial tests if the weight-loss drug tirzepatide can help people with obesity-related endometrial cancer before their hysterectomy. It may improve surgical outcomes and overall health.
Chapel Hill, North CarolinaAges 18 years+ - NCT07108270RecruitingPhase 2
Study of dostarlimab plus chemotherapy for advanced or recurrent endometrial cancer
This trial tests a combination of the immunotherapy drug dostarlimab with standard chemotherapy (carboplatin and paclitaxel) for people with advanced or recurrent endometrial cancer that has a specific genetic feature called dMMR or MSI-H. The goal is to see if this combination works better than chemotherapy alone.
Jinan, ShandongAges 18 years+ - NCT07114653Recruiting
Study of POLE mutation in high-risk endometrial cancer
This trial looks at a specific genetic change called POLE mutation in women with endometrial cancer that has a high risk of coming back. It may help doctors understand who could benefit from different treatments.
Banqiao District, New TaipeiAges Any age - NCT07116213Recruiting
Shorter radiation after surgery for high-risk endometrial cancer
This trial studies a new type of radiation therapy (called online adaptive radiotherapy) given in shorter, higher daily doses after surgery for high-risk endometrial cancer. The goal is to see if this approach is safe and effective for reducing side effects while still controlling the cancer.
Beijing, Beijing MunicipalityAges 18–70 - NCT07148154Recruiting
Non-invasive test for endometrial cancer screening
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
L'Hospitalet de Llobregat, BarcelonaAges 40 years+ - NCT07195305Recruiting
Treating adenomyosis bleeding with heat or artery blocking
This study compares two treatments for heavy bleeding caused by adenomyosis: a procedure that uses heat to remove the inner lining of the uterus (endometrial ablation) and a procedure that blocks blood flow to the uterus (uterine artery embolization). If you have been diagnosed with adenomyosis and have tried medication without success, this trial may help decide which treatment is best for you.
BordeauxAges 30–50 - NCT07220239Recruiting
Menstrual cup for early cancer detection in Lynch syndrome
This study tests whether a menstrual cup can collect cells from the uterus to detect early endometrial cancer in women with Lynch syndrome. If you have Lynch syndrome and are due for a routine biopsy, you may be able to use a menstrual cup instead.
Boston, MassachusettsAges 18 years+ - NCT07278986RecruitingEarly Phase 1
Imaging dye during endometrial cancer surgery
This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07318415Recruiting
Ultrasound imaging study for endometrial cancer
This study tests a new ultrasound technique (multiparametric ultrasound) to see if it can better image endometrial cancer after surgery. It is for people who have had their cancer removed and will receive radiation therapy.
Basking Ridge, New JerseyAges 18 years+ - NCT07319429RecruitingPhase 2/Phase 3
Fertility-sparing treatment for endometrial cancer based on molecular type
This trial tests a tailored approach to preserve fertility in women with early-stage endometrial cancer, using medications like hormones and immunotherapy based on the tumor's molecular subtype. It aims to avoid hysterectomy and keep the uterus intact.
Shanghai, Shanghai MunicipalityAges 18–45
Hear when a new Endometrial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for endometrial?
- Yes. Clin2 currently lists 364 recruiting endometrial studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a endometrial trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a endometrial trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.